tHEORetically Speaking
By HealthEconomics.com
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by HealthEconomics.com
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 86
Description
Insights, observations, and executive interviews that discuss data and evidence to guide value-based decisions in health care. For more, visit our blog: https://healtheconomics.com/theoretically-speaking/
| Episode | Date |
|---|---|
|
Weekly News Roundup — Wegovy Pill’s Historic Debut, Lilly’s Manufacturing Expansion, and Robotic GI Breakthroughs
|
May 08, 2026 |
|
Weekly News Roundup — Real-Time Clinical Trials, Canadian Breast Cancer Standards, and FDA Data Integrity Concerns
|
May 01, 2026 |
|
INsights & OUTcomes with Mark Larkin
|
Apr 20, 2026 |
|
Weekly News Roundup — PhRMA Leadership Transition, The ICHRA Shift, and MDUFA VI Preliminary Deal
|
Apr 10, 2026 |
|
Weekly News Roundup — Medtech Mega Deals, EU Regulatory Delays, and Global Supply Chain Shock
|
Mar 27, 2026 |
|
Weekly News Roundup — Medicaid Maternal Care Expansion, Breakthrough Diabetes Data, and SMA Market Shakeups
|
Mar 20, 2026 |
|
Weekly News Roundup — Biosimilar Policy Changes, mRNA Leadership Shifts, and Rare Disease Market Growth
|
Mar 13, 2026 |
|
Weekly News Roundup — mRNA Vaccine Milestones, Obesity Drug Manufacturing, and Gene Therapy Regulatory Tensions
|
Mar 06, 2026 |
|
INsights & OUTcomes with Radek Wasiak
|
Feb 27, 2026 |
|
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
|
Feb 23, 2026 |
|
Weekly News Roundup — RSV Breakthrough Data, Psychedelic Approvals on the Horizon, and Major FDA Policy Shifts
|
Feb 20, 2026 |
|
Weekly News Roundup — AI Drug Discovery Deals, mRNA Regulatory Setbacks, and Global Investment Shifts
|
Feb 13, 2026 |
|
Weekly News Roundup — Regulatory RWE Battles, Capital Market Moves, and Cash-Pay Drug Pricing Disruption
|
Feb 06, 2026 |
|
INsights & OUTcomes with Taylor Hirschberg
|
Feb 02, 2026 |
|
Weekly News Roundup — Rare Disease Funding Risks, Medicare Advantage Reform, and Global Trade Shifts
|
Jan 30, 2026 |
|
Weekly News Roundup — Oral GLP-1 Momentum, Trade Tensions, EU Drug Security, and AI Risk Warnings
|
Jan 23, 2026 |
|
Weekly News Roundup — Neurodegeneration Deals, Generative AI, and Drug Pricing Politics
|
Jan 16, 2026 |
|
Weekly News Roundup — Oncology Shakeups, FDA Wellness Crackdown, and AI-Powered Drug Discovery
|
Dec 12, 2025 |
|
Weekly News Roundup — Tariff-Free Pharma, Biologics Modernization, Duchenne Trial Success, and Maternal Health Advances
|
Dec 05, 2025 |
|
Weekly News Roundup — Premium Hikes, Predictive AI Breakthroughs, and Public Health Policy Fallout
|
Nov 21, 2025 |
|
Weekly News Roundup — Four Big Moves in Medtech, Neurotech, Biopharma R&D & Pharma M&A
|
Nov 14, 2025 |
|
Weekly News Roundup – FDA Shakeups, Novo Nordisk’s Strategic Reset, and Smart Data for Diabetes Innovation
|
Nov 07, 2025 |
|
Weekly News Roundup – Neuro Breakthroughs, Biosimilar Reform, and an Obesity Drug Showdown
|
Oct 31, 2025 |
|
Weekly News Roundup – Real-World Wins and Billion-Dollar Breakthroughs
|
Oct 24, 2025 |
|
INsights & OUTcomes with Dalfoni Banerjee
|
Oct 21, 2025 |
|
Weekly News Roundup – CAR-T Safety Alerts, Policy Ripple Effects, and Notable Wearables
|
Oct 17, 2025 |
|
Weekly News Roundup – Immunology, Innovation, and Impact
|
Oct 10, 2025 |
|
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
|
Oct 06, 2025 |
|
Weekly News Roundup – Medicaid Deals, Oncology Innovation, and Market Tensions Abroad
|
Oct 03, 2025 |
|
INsights & OUTcomes with Renée Arnold
|
Sep 30, 2025 |
|
Weekly News Roundup – Public Health Flashpoints, Pharma Innovation, and Pricing Battles
|
Sep 26, 2025 |
|
Weekly News Roundup – Vaccine Policy Shifts, AI-Powered R&D, and Billion-Dollar Investments
|
Sep 19, 2025 |
|
Weekly News Roundup – Pharma Acquisitions, Trial Triumphs, and Coding Controversies
|
Sep 12, 2025 |
|
Weekly News Roundup – Obesity Drug Rivalry, Rare Disease Pathways, Vaccine Mandate Battles, and ACA Shake-Ups
|
Sep 05, 2025 |
|
Weekly News Roundup – Ransomware Shocks, Vaccine Policy Shifts, and Billion-Dollar Pharma Investments
|
Aug 29, 2025 |
|
Weekly News Roundup – Alzheimer’s Breakthroughs, Cancer Trial Advances, and High-Stakes Policy Battles
|
Aug 22, 2025 |
|
Weekly News Roundup - Pharmacist Empowerment, Financial Shifts, and Innovative Health Solutions
|
Aug 15, 2025 |
|
Weekly News Roundup - Pharma Pilots, Legal Battles, and Precision Medicine Breakthroughs
|
Aug 08, 2025 |
|
Weekly News Roundup - Vaccine Triumphs, Revolutionary Trials, and Data-Driven Health Futures
|
Aug 01, 2025 |
|
tHEORetically Speaking: Meeting the Resource Challenge - Why Biotechs Need a Different Kind of Partner
|
Jul 28, 2025 |
|
INsights & OUTcomes with Matt McLoughlin
|
Jun 10, 2025 |
|
INsights & OUTcomes with Catherine Bacon
|
May 20, 2025 |
|
INsights & OUTcomes with Vernon Schabert
|
Apr 28, 2025 |
|
INsights & OUTcomes with Rosa Willock
|
Mar 31, 2025 |
|
INsights & OUTcomes with Chris O'Neill
|
Mar 10, 2025 |
|
INsights & OUTcomes - COMING SOON to tHEORetically Speaking
|
Feb 24, 2025 |
|
tHEORetically speaking: Making Real-World Data Research-Ready
|
Nov 07, 2024 |
|
tHEORetically speaking: Between Two Scientists: Care During Pregnancy - How RWD Can Help Balance the Needs of Mom and Baby
|
Sep 24, 2024 |
|
tHEORetically speaking: How AI-Powered Phenotyping Enhances the Patient Journey for Life Science Applications
|
Apr 25, 2024 |
|
tHEORetically speaking: EU HTA Joint Clinical Assessments
|
Mar 14, 2024 |
|
tHEORetically speaking: Clinical Outcomes Assessments and Training
|
Mar 14, 2024 |
|
tHEORetically speaking: Cell & Gene Therapies
|
Mar 14, 2024 |
|
tHEORetically speaking: Patient-Centered Real-World Evidence in Rare Diseases
|
Mar 13, 2024 |
|
tHEORetically speaking: Real-World Evidence Generation with Disease Registries
|
Mar 11, 2024 |
|
tHEORetically speaking: Clinical Outcome Assessment (COA) Translations
|
Mar 11, 2024 |
|
tHEORetically speaking: Between Two Scientists - New Types of Data
|
Mar 04, 2024 |
|
tHEORetically speaking: Total System Value™ - A DYNAMIC APPROACH TO VALUE DEMONSTRATION
|
Jan 08, 2024 |
|
tHEORetically speaking: Between Two Scientists - Labeling and Certifying your Varietal Data Blend
|
Nov 29, 2023 |
|
tHEORetically speaking: How AI Can Help Dermatology: Diagnosis, Treatment, Risk, and R&D
|
Nov 15, 2023 |
|
tHEORetically speaking: The Future of Diversity in Clinical Trials: Real-World Evidence
|
Oct 30, 2023 |
|
tHEORetically speaking: Between Two Scientists - Data Linkage
|
Sep 27, 2023 |
|
tHEORetically speaking: Detecting and Decoding Alzheimer's with Real-World Data
|
Sep 20, 2023 |
|
tHEORetically speaking: Leveraging Real-World Data for Precision Obesity Treatment
|
Jul 26, 2023 |
|
tHEORetically speaking: Medicare and Medicaid Services Market Pricing
|
Jul 06, 2023 |
|
tHEORetically speaking: Medicare Data for RWD Analysis
|
Jul 04, 2023 |
|
tHEORetically speaking: The Benefits of Linking SDOH Data with Other Real-World Data
|
May 11, 2023 |
|
tHEORetically speaking: Improving the Representativeness of Research
|
Apr 12, 2023 |
|
tHEORetically speaking: Literature Reviews and Global Value Dossiers
|
Apr 05, 2023 |
|
tHEORetically speaking: Causal Inference In Real-World Healthcare Data
|
Feb 07, 2023 |
|
tHEORetically speaking: Health Economics and Outcome Research for Medical Technology
|
Feb 07, 2023 |
|
tHEORetically speaking: Exploring Social Media Data in Different Contexts
|
Dec 12, 2022 |
|
tHEORetically speaking: Discussing Health Technology Assessment Agencies
|
Dec 09, 2022 |
|
tHEOretically speaking: Platforms and Models for Payer Insights and Evidence Generation
|
Dec 08, 2022 |
|
tHEORetically speaking: Delphi panels
|
Dec 05, 2022 |
|
tHEORetically speaking: Improving Health Literacy
|
Nov 29, 2022 |
|
tHEORetically speaking: Infectious Disease Modeling
|
Nov 22, 2022 |
|
tHEORetically speaking: Getting Real About Real-World Data
|
Nov 17, 2022 |
|
tHEORetically speaking: Utilizing RWD, Machine Learning, and System Biology
|
Oct 27, 2022 |
|
tHEORetically speaking: How Accelerated Drug Development Requires Disruption in Market Access and Pricing
|
Oct 13, 2022 |
|
tHEORetically speaking: Evidence Generation Planning
|
Aug 18, 2022 |
|
tHEORetically speaking: Renee Willmon on Health Storylines
|
Jul 15, 2022 |
|
tHEORetically speaking: Information for Healthcare Decision-Makers
|
Jul 12, 2022 |
|
tHEORetically speaking: Embracing FDA Guidance on Real World Data
|
Jun 23, 2022 |
|
tHEORetically speaking: Algorithms for Real World Evidence
|
Jun 21, 2022 |
|
tHEORetically speaking: Real-World Evidence and Neonatal Outcomes
|
Jun 16, 2022 |
|
tHEORetically speaking: Literature Review Automation
|
May 30, 2022 |